Rockwell Medical, Inc. (RMTI)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$6.82
—
Mkt Cap $35.57M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+193.3%
Consensus $20.00 vs current $6.82